Condition: Lower Respiratory Tract Infection · Sponsor: MeMed Diagnostics Ltd.
This is a Prospective, multi-center study enrolling adults subjects presented to the ED/Urgent care, with symptoms consistent with lower respiratory infection (LRTI). The reason of this study is to demonstrate the MeMed BV can help clinicians make decisions about using antibiotics in patients with lower respiratory track infections and see how it would impact clinical outcomes, antibiotics use, hospitalizations, ED clinicians find ways to improve health and medical care.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| University of Florida-Jacksonville | Jacksonville, Florida, United States | Recruiting |
| University of Kansas Medical Center | Kansas City, Kansas, United States | Recruiting |
| Maimonides Medical Center | Brooklyn, New York, United States | Recruiting |
| Stony Brook University Hospital | Stony Brook, New York, United States | Recruiting |
| Philadelphia Thomas Jefferson ED | Philadelphia, Pennsylvania, United States | Recruiting |
| Medical University South Carolina | Charleston, South Carolina, United States | Recruiting |
| UT Southwestern Medical Center | Dallas, Texas, United States | Recruiting |
| MCW | Milwaukee, Wisconsin, United States | Recruiting |
| Carmel Medical Center | Haifa, North, Israel | Recruiting |
| Lin Medical Center | Haifa, Israel | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05762302